The MSF Scientific Days International conference is a platform for researchers, innovators, and advocates in humanitarian global health to come together to discuss and challenge research from within the sector.
Session
From trials to tools: solutions for humanitarian health
Time: 9:45 BST
| Antibiogo as an innovative solution to detect antimicrobial resistance: From an operational need to a CE-marked diagnostic test available for low-income and middle-income countries Nada Malou, Antibiogo Program Manager, MSF |
| Malaria Anticipation Project: Development of a predictive malaria early warning system for anticipatory action in Jonglei State, South Sudan Tom Wardley, MSF Kim West, MSF |
| Application of the Médecins Sans Frontières clinical trial transparency policy: cost analysis of TB-PRACTECAL, a multicentre phase 2–3 trial in drug-resistant tuberculosis Dzintars Gotham, Consultant, MSF |
| Once-weekly fosravuconazole versus daily itraconazole, with surgery, in eumycetoma patients in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial Ahmed Fahal, Director, Mycetoma Research Center |
